Dry Age Related Macular Degeneration clinical trials

Explore recruiting dry age related macular degeneration clinical trials.

Recruiting dry age related macular degeneration studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Dry Age Related Macular Degeneration trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An open-label safety and tolerability clinical trial of PST-611 in dry age-related macular degeneration.

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

ReNEW: A Phase 3, Randomized, Double-Masked, Placebo-Controlled Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects who have Dry Age-Related Macular Degeneration (Dry AMD)

Italy, Hungary, Germany, Czechia, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2 Multicenter, Randomized, Double-masked, Sham-controlled, Reference-arm Study to Evaluate Efficacy and Safety of ONL1204 in Patients With Geographic Atrophy (GA) Associated With Age-related Macular Degeneration (AMD)

Czechia, Hungary, Germany, Austria, Italy, Spain +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

CellThRPE1

Sweden

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 3, Multicenter, Randomized, Parallel-Group, Double-Masked, 2-Arm, Sham Controlled Study of the Efficacy, Safety, and Tolerability of ANX007 (Vonaprument) Administered by Intravitreal Injection in Participants with Dry Age-Related Macular Degeneration with Geographic Atrophy

Italy, France, Poland, Germany, Hungary, Spain +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized, double masked, placebo-controlled, multicenter, dose-range finding study to assess the efficacy and safety of FWY003 in patients with geographic atrophy secondary to age-related macular degeneration

Bulgaria, Romania, Germany, Czechia, Spain, Poland +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Dry Age Related Macular Degeneration clinical trials

Recruiting dry age related macular degeneration studies right now

Stem Cell Ophthalmology Treatment Study II

Post-market Clinical Investigation of the SING IMT System, Model NG SI IMT 3X in Patients With End-stage Age-related Macular Degeneration

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

Effects of Antiplatelet and Antioxidant Agents on Drusen Progression: A Pilot, Prospective Cohort Study

Atrophic Age-related Macular Degeneration Treated With Intravitreal Injections of Umbilical Cord Blood Platelet-rich Plasma

Age-related Macular Degeneration of Atrophic Type Treated With Umbilical Cord Blood Enriched With Platelet Plasma.

A Phase 1/2 Study to Evaluate the Safety and Efficacy of Intravitreal Administration of BS01 in Patients With Geographic Atrophy Secondary to Dry AMD

Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.

Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression

Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study

(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000

Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration